AGENUS INC Share-based Payment Arrangement, Expense
AGENUS INC (AGEN) reported Share-based Payment Arrangement, Expense of $3.26 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-07
- AGENUS INC share-based payment arrangement, expense for the quarter ending 2026-06-30 was $3.26M, a 5.26% decline year-over-year.
- AGENUS INC share-based payment arrangement, expense for the quarter ending 2026-03-31 was $866.00K, a 74.02% decline year-over-year.
- AGENUS INC share-based payment arrangement, expense for the quarter ending 2025-12-31 was $2.31M, a 49.27% decline year-over-year.
- AGENUS INC share-based payment arrangement, expense for the quarter ending 2025-09-30 was $2.81M, a 69.74% decline year-over-year.
- AGENUS INC share-based payment arrangement, expense for fiscal 2025 was $11.90M, a 56.47% decline from fiscal 2024.
- AGENUS INC share-based payment arrangement, expense for fiscal 2024 was $27.33M, a 22.26% increase from fiscal 2023.
- AGENUS INC share-based payment arrangement, expense for fiscal 2023 was $22.35M, a 22.55% increase from fiscal 2022.
- AGENUS INC share-based payment arrangement, expense for fiscal 2022 was $18.24M, a 4.68% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.26M 10-Q · filed 2026-08-07 | $4.13M 10-Q · filed 2026-08-07 | $6.44M derived: sum of 3 quarters · filed 2026-08-07 | $9.25M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $866.00K 10-Q · filed 2026-05-11 | $3.18M derived: sum of 2 quarters · filed 2026-05-11 | $5.99M derived: sum of 3 quarters · filed 2026-05-11 | $9.43M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $5.12M derived: sum of 2 quarters · filed 2026-03-16 | $8.56M derived: sum of 3 quarters · filed 2026-08-07 | $11.90M 10-K · filed 2026-03-16 |
| 2025-09-30 | $2.81M 10-Q · filed 2025-11-10 | $6.25M derived: sum of 2 quarters · filed 2026-08-07 | $9.58M 10-Q · filed 2025-11-10 | $14.14M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $3.44M 10-Q · filed 2026-08-07 | $6.77M 10-Q · filed 2026-08-07 | $11.34M derived: sum of 3 quarters · filed 2026-08-07 | $20.61M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $3.33M 10-Q · filed 2026-05-11 | $7.89M derived: sum of 2 quarters · filed 2026-05-11 | $17.17M derived: sum of 3 quarters · filed 2026-05-11 | $26.46M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $4.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $13.84M derived: sum of 2 quarters · filed 2026-03-16 | $23.13M derived: sum of 3 quarters · filed 2026-03-16 | $27.33M 10-K · filed 2026-03-16 |
| 2024-09-30 | $9.28M 10-Q · filed 2025-11-10 | $18.57M derived: sum of 2 quarters · filed 2025-11-10 | $22.77M 10-Q · filed 2025-11-10 | $28.05M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | $9.29M 10-Q · filed 2025-08-11 | $13.49M 10-Q · filed 2025-08-11 | $18.77M derived: sum of 3 quarters · filed 2026-03-16 | $24.31M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | $4.20M 10-Q · filed 2025-05-12 | $9.48M derived: sum of 2 quarters · filed 2026-03-16 | $15.02M derived: sum of 3 quarters · filed 2026-03-16 | $21.06M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-31 | $5.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $10.82M derived: sum of 2 quarters · filed 2026-03-16 | $16.87M derived: sum of 3 quarters · filed 2026-03-16 | $22.35M 10-K · filed 2026-03-16 |
| 2023-09-30 | $5.54M 10-Q · filed 2024-11-12 | $11.58M derived: sum of 2 quarters · filed 2024-11-12 | $17.06M 10-Q · filed 2024-11-12 | $21.30M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | $6.04M 10-Q · filed 2024-08-08 | $11.53M 10-Q · filed 2024-08-08 | $15.77M derived: sum of 3 quarters · filed 2025-03-17 | $20.20M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | $5.49M 10-Q · filed 2024-05-07 | $9.73M derived: sum of 2 quarters · filed 2025-03-17 | $14.16M derived: sum of 3 quarters · filed 2025-03-17 | $18.78M derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | $4.24M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $8.68M derived: sum of 2 quarters · filed 2025-03-17 | $13.29M derived: sum of 3 quarters · filed 2025-03-17 | $18.24M 10-K · filed 2025-03-17 |
| 2022-09-30 | $4.43M 10-Q · filed 2023-11-09 | $9.05M derived: sum of 2 quarters · filed 2023-11-09 | $14.00M 10-Q · filed 2023-11-09 | $18.99M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-06-30 | $4.62M 10-Q · filed 2023-08-08 | $9.56M 10-Q · filed 2023-08-08 | $14.56M derived: sum of 3 quarters · filed 2024-03-14 | $19.33M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-03-31 | $4.95M 10-Q · filed 2023-05-09 | $9.94M derived: sum of 2 quarters · filed 2024-03-14 | $14.72M derived: sum of 3 quarters · filed 2024-03-14 | $20.15M derived: sum of 4 quarters · filed 2024-03-14 |
| 2021-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $9.77M derived: sum of 2 quarters · filed 2024-03-14 | $15.20M derived: sum of 3 quarters · filed 2024-03-14 | $19.13M 10-K · filed 2024-03-14 |
| 2021-09-30 | $4.78M 10-Q · filed 2022-11-08 | $10.21M derived: sum of 2 quarters · filed 2022-11-08 | $14.14M 10-Q · filed 2022-11-08 | $16.78M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $5.43M 10-Q · filed 2022-08-09 | $9.36M 10-Q · filed 2022-08-09 | $12.00M derived: sum of 3 quarters · filed 2023-03-16 | $14.62M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-03-31 | $3.93M 10-Q · filed 2022-05-10 | $6.57M derived: sum of 2 quarters · filed 2023-03-16 | $9.19M derived: sum of 3 quarters · filed 2023-03-16 | $11.66M derived: sum of 4 quarters · filed 2023-03-16 |
| 2020-12-31 | $2.64M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $5.26M derived: sum of 2 quarters · filed 2023-03-16 | $7.72M derived: sum of 3 quarters · filed 2023-03-16 | $10.12M 10-K · filed 2023-03-16 |
| 2020-09-30 | $2.62M 10-Q · filed 2021-11-09 | $5.08M derived: sum of 2 quarters · filed 2021-11-09 | $7.48M 10-Q · filed 2021-11-09 | $10.53M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $2.46M 10-Q · filed 2021-08-09 | $4.86M 10-Q · filed 2021-08-09 | $7.91M derived: sum of 3 quarters · filed 2022-03-01 | $10.99M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $2.40M 10-Q · filed 2021-05-07 | $5.45M derived: sum of 2 quarters · filed 2022-03-01 | $8.53M derived: sum of 3 quarters · filed 2022-03-01 | $10.45M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $3.05M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $6.13M derived: sum of 2 quarters · filed 2022-03-01 | $8.05M derived: sum of 3 quarters · filed 2022-03-01 | $9.89M 10-K · filed 2022-03-01 |
| 2019-09-30 | $3.08M 10-Q · filed 2020-11-09 | $5.00M derived: sum of 2 quarters · filed 2020-11-09 | $6.84M 10-Q · filed 2020-11-09 | $8.77M derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | $1.92M 10-Q · filed 2020-08-10 | $3.76M 10-Q · filed 2020-08-10 | $5.69M derived: sum of 3 quarters · filed 2021-03-16 | $7.59M derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-03-31 | $1.84M 10-Q · filed 2020-05-11 | $3.77M derived: sum of 2 quarters · filed 2021-03-16 | $5.68M derived: sum of 3 quarters · filed 2021-03-16 | $7.26M derived: sum of 4 quarters · filed 2021-03-16 |
| 2018-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $3.83M derived: sum of 2 quarters · filed 2021-03-16 | $5.42M derived: sum of 3 quarters · filed 2021-03-16 | $7.63M 10-K · filed 2021-03-16 |
| 2018-09-30 | $1.91M 10-Q · filed 2019-11-07 | $3.49M derived: sum of 2 quarters · filed 2019-11-07 | $5.70M 10-Q · filed 2019-11-07 | $11.04M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | $1.58M 10-Q · filed 2019-08-09 | $3.79M 10-Q · filed 2019-08-09 | $9.13M derived: sum of 3 quarters · filed 2020-03-16 | $11.09M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-03-31 | $2.21M 10-Q · filed 2019-05-10 | $7.55M derived: sum of 2 quarters · filed 2020-03-16 | $9.51M derived: sum of 3 quarters · filed 2020-03-16 | $12.26M derived: sum of 4 quarters · filed 2020-03-16 |
| 2017-12-31 | $5.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $7.30M derived: sum of 2 quarters · filed 2020-03-16 | $10.05M derived: sum of 3 quarters · filed 2020-03-16 | $12.43M 10-K · filed 2020-03-16 |
| 2017-09-30 | $1.96M 10-Q · filed 2018-11-07 | $4.71M derived: sum of 2 quarters · filed 2018-11-07 | $7.08M 10-Q · filed 2018-11-07 | $11.57M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | $2.75M 10-Q · filed 2018-08-09 | $5.13M 10-Q · filed 2018-08-09 | $9.62M derived: sum of 3 quarters · filed 2019-03-18 | $12.00M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-03-31 | $2.38M 10-Q · filed 2018-05-10 | $6.86M derived: sum of 2 quarters · filed 2019-03-18 | $9.25M derived: sum of 3 quarters · filed 2019-03-18 | $10.80M derived: sum of 4 quarters · filed 2019-03-18 |
| 2016-12-31 | $4.49M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $6.87M derived: sum of 2 quarters · filed 2019-03-18 | $8.43M derived: sum of 3 quarters · filed 2019-03-18 | $13.19M 10-K · filed 2019-03-18 |
| 2016-09-30 | $2.38M 10-Q · filed 2017-11-07 | $3.94M derived: sum of 2 quarters · filed 2017-11-07 | $8.70M 10-Q · filed 2017-11-07 | $10.92M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | $1.55M 10-Q · filed 2017-08-07 | $6.32M 10-Q · filed 2017-08-07 | $8.54M derived: sum of 3 quarters · filed 2018-03-16 | $9.31M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | $4.76M 10-Q · filed 2017-05-04 | $6.98M derived: sum of 2 quarters · filed 2018-03-16 | $7.75M derived: sum of 3 quarters · filed 2018-03-16 | $10.71M derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | $2.22M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $2.99M derived: sum of 2 quarters · filed 2018-03-16 | $5.95M derived: sum of 3 quarters · filed 2018-03-16 | $7.44M 10-K · filed 2018-03-16 |
| 2015-09-30 | $773.00K 10-Q · filed 2016-11-09 | $3.73M derived: sum of 2 quarters · filed 2016-11-09 | $5.22M 10-Q · filed 2016-11-09 | $6.19M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $2.95M 10-Q · filed 2016-08-04 | $4.45M 10-Q · filed 2016-08-04 | $5.42M derived: sum of 3 quarters · filed 2017-03-16 | $6.70M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $1.49M 10-Q · filed 2016-05-09 | $2.46M derived: sum of 2 quarters · filed 2017-03-16 | $3.74M derived: sum of 3 quarters · filed 2017-03-16 | |
| 2014-12-31 | $971.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $2.25M derived: sum of 2 quarters · filed 2017-03-16 | $4.67M 10-K · filed 2017-03-16 | |
| 2014-09-30 | $1.28M 10-Q · filed 2015-11-04 | $3.70M 10-Q · filed 2015-11-04 | ||
| 2013-12-31 | $4.13M 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |